Company Filing History:
Years Active: 2019-2020
Title: Innovations of Lianiqing Jiang
Introduction
Lianiqing Jiang is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for producing important compounds.
Latest Patents
Lianiqing Jiang holds two patents that focus on the production of milbemycin, a compound with various applications. His latest patents include a method for producing milbemycin A4 using Streptomyces HS7522, which was deposited in the China General Microbiological Culture Collection Center with the accession number CGMCC No. 9671 on September 16, 2014. Additionally, he has developed a method for preparing milbemycin A3 by culturing Streptomyces HS7523, which is also deposited in the same center with the accession number CGMCC No. 9672 on the same date.
Career Highlights
Lianiqing Jiang is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His work has been instrumental in advancing the production methods of vital compounds.
Collaborations
He collaborates with talented coworkers, including Yun Teng and Meidong Xu, who contribute to his research and development efforts.
Conclusion
Lianiqing Jiang's work in the field of pharmaceuticals, particularly in the production of milbemycin, showcases his innovative spirit and dedication to advancing medical science. His contributions are valuable to the industry and highlight the importance of research and development in creating effective pharmaceutical solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.